03/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
02/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
01/07/2025
|
15:00
|
Total Voting Rights
|
RNS
|
01/07/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
30/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
27/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
26/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
25/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
24/06/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
24/06/2025
|
15:00
|
Director Declaration
|
RNS
|
24/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
23/06/2025
|
17:50
|
Replacement - Director/PDMR Shareholding
|
RNS
|
23/06/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
23/06/2025
|
08:30
|
Replacement RNS: Linerixibat file accepted by EMA
|
RNS
|
23/06/2025
|
08:18
|
GSK Submits Arexvy for adults 18+ with EMA
|
RNS
|
23/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
20/06/2025
|
07:00
|
Arexvy filed in Japan for 18-49 at increased risk
|
RNS
|
20/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
19/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
18/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
17/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
16/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
13/06/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
13/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
13/06/2025
|
07:00
|
GSK submits Arexvy for adults 18+ with EMA
|
RNS
|
12/06/2025
|
11:00
|
Director/PDMR Shareholding
|
PR Newswire
|
12/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
11/06/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
11/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
10/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
09/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
06/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
05/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
04/06/2025
|
07:00
|
GSK - second tranche of share buyback programme
|
RNS
|
04/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
03/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
02/06/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
02/06/2025
|
15:00
|
Total Voting Rights
|
RNS
|
02/06/2025
|
07:00
|
Linerixibat file accepted for review by US FDA
|
RNS
|
02/06/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
30/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
29/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
28/05/2025
|
12:00
|
GSK stops Phase 3 trial on cUTIs for efficacy
|
RNS
|
28/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
27/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
23/05/2025
|
12:16
|
positive CHMP opinion on Blenrep in EU
|
RNS
|
23/05/2025
|
07:00
|
FDA approves Nucala COPD indication
|
RNS
|
23/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
22/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
21/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|